Abstract:Background:With the emergence of bacterial resistance,the efficacy of Helicobacter pylori(Hp)eradication therapy is decreasing in recent years. After the previous failed course of eradication therapy,the possibility of failure of re-eradication therapy is greater. Therefore,choosing the rescue therapy for Hp re-eradication is particularly important. Aims:To investigate the efficacy of levofloxacin-based triple therapy combined with probiotics as a rescue therapy for Hp re-eradication. Methods:A total of 192 patients with a previous failed course of standard triple therapy for Hp eradication were enrolled and randomly assigned into four groups. Group A:lansoprazole 30 mg + amoxicillin 1 000 mg + levofloxacin 200 mg bid for 14 days;group B:regimen of group A with the addition of bismuth potassium citrate 600 mg bid for 14 days;group C:bifidobacterium and lactobacillus triple live bacteria 2 000 mg tid for 14 days followed by regimen of group A for 14 days;group D:regimen of group A with the addition of bifidobacterium and lactobacillus triple live bacteria 2 000 mg tid for 14 days. At 4 weeks after end of treatment,Hp eradication was assessed by 13 C-urea breath test. Adverse effects during the course of treatment were recorded. Results:A total of 177(92. 2% )patients completed the study,the completion rates in group A,B,C and D were 87. 5%(42 / 48),83. 3%(40 / 48),97. 9%(47 / 48)and 100% , respectively;the completion rates in group C and D were significantly higher than those in group A and B(P < 0. 05). By intention-to-treat(ITT)analysis,the eradication rates of group A,B,C and D were 60. 4% ,68. 8% ,81. 3% and 83. 3% ,respectively;the eradication rates in group C and D were significantly higher than that in group A(χ2 = 5. 042, P = 0. 045;χ2 = 6. 235,P = 0. 013). By per-protocol(PP)analysis,the eradication rates of group A,B,C and D were 69. 0% ,82. 5% ,83. 0% and 83. 3% ,respectively;no statistically significant differences were found among the four groups(P > 0. 05). Adverse effects included constipation,taste distortion,bloating and anorexia,the incidences of adverse effects in group A,B,C and D were 79. 2% ,95. 8% ,29. 2% and 22. 9% ,respectively;the incidences in group C and D were significantly lower than those in group A and B(P < 0. 05). Conclusions:Levofloxacin-based triple therapy combined with bifidobacterium and lactobacillus triple live bacteria can decrease the adverse effects of traditional triple and quadruple therapies and improve the patient compliance,thus increases the efficacy of rescue therapy for Hp re-eradication.

Efficacy of Quadruple Therapy with Rufloxacin and Dual Therapy with High Dose Amoxicillin as Rescue Regimens for Failure of Helicobacter pylori Eradication

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for <i>Helicobacter pylori</i> infection: a protocol of a single-centre, single-blind, randomised clinical trial in China

Efficacy of Levofloxacin-based Triple Therapy Combined with Probiotics as A Rescue Therapy for Helicobacter pylori Re-eradication

[Efficacy and Safety of 14-Day Amoxicillin and Furazolidone-Based Quadruple Rescue Regimen for Eradication of Helicobacter Pylori: a Retrospective Study].

Outcomes of Furazolidone- and Amoxicillin-Based Quadruple Therapy for Helicobacter Pylori Infection and Predictors of Failed Eradication.

Eradication Efficacy of Sequential Therapy Versus Standard Quadruple Therapy As Rescue Therapies for Failure of Helicobacter Pylori Eradication

Clinical Study of Doxycycline-based Quadruple Regimen as a Rescue Therapy after Failure of Initial Eradication Therapy of Helicobacter pylori

Furazolidone, Amoxicillin, Bismuth and Rabeprazole Quadruple Rescue Therapy for the Eradication of Helicobacter Pylori

Levofloxacin based quadruple therapy for helicobacter pylori rescue eradication:a meta-analysis

Quadruple Therapy with Medications Containing Either Rufloxacin or Furazolidone As a Rescue Regimen in the Treatment of Helicobacter Pylori-Infected Dyspepsia Patients: A Randomized Pilot Study

Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy

Outcomes of bismuth-containing quadruple rescue regimen in treating helicobacter pylori-positive patients failed to the first-line eradication regimen

Tetracycline- and Furazolidone-Containing Quadruple Regimen As Rescue Treatment for Helicobacter Pylori Infection: A Single Center Retrospective Study

Efficacy and Safety of Berberine-containing Quadruple Regimen As Rescue Therapy for Helicobacter Pylori Eradication

High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.

[Efficacy of Triple Versus Quadruple Furazolidone-Based Eradication Regimens for Helicobacter Pylori Infection].

Quadruple therapy of rabeprazole and ranitidine bismuth citrate for eradicating helicobacter pylori infection

[Efficacy of 4 Kinds of Triple Strategy for Helicobacter Pylori Eradication].

Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of <i>Helicobacter pylori</i> infection previously failed in eradication: A real-world, retrospective clinical study in China

[Dual Therapy with Rabeprazole and Amoxicillin Four Times Daily for 14 Days for the First-Line Eradication of Helicobacter Pylori Infection].

Efficacy of Levofloxacin and Bismuth-Containing Quadruple Therapy for the Eradication of Helicobacter Pylori